|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8040 EUR | +1.77% |
|
+4.42% | +15.85% |
| 23/07 | Valbiotis Publishes Results of Reverse-It Clinical Study Evaluating Totum 63 in Nature Communications | CI |
| 29/06 | Valbiotis Raises EUR10 Million for Commercial Development, Working Capital | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- ALVAL Stock
- Consensus Valbiotis
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
